| mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
| mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |
| mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
0.0033 |
0.9 |
| mRNA |
pac-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
| mRNA |
CEP-701 |
GDSC1000 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0024 |
0.9 |
| mRNA |
PHA-793887 |
GDSC1000 |
pan-cancer |
AAC |
-0.0018 |
0.9 |
| mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
0.9 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0022 |
0.9 |
| mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
-0.0019 |
0.9 |